By Ben Hirschler LONDON (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday its $2.6 billion bid for long-time partner Human Genome...
if you're on a regimen of prescription drugs, you already know how expensive prescription drugs can be -- and you may have found yourself comparing prices among pharmacies. What would happen to this diversity, and to patients, if one company -- one pharmacy -- were to engage in monopolistic behavior?